ANRO · ISSUER CIK 1999480
Alto Neuroscience, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 1 Alto Neuroscience, Inc. insiders reported $0.00 of open-market purchases and $3.6M of sales on SEC Form 4.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 1 of 1 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$3.6MInsider selling
−$3.6MNet open-market
Oct 5, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 5, 202616:59 | Oct 2, 2026 | ANRO | PRESIDENT AND CFO | M · Exercise | $2.32 | +55,000 | 79,060 | +229% | $128K | ||
| Oct 1, 202621:33 | Sep 30, 2026from Sep 29, 2026 | ANRO | PRESIDENT AND CFO | S · Sell10b5-1 | $26.45 | −134,886 | 24,060 | -85% | −$3.6M | ||
| Oct 1, 202621:33 | Sep 30, 2026from Sep 29, 2026 | ANRO | PRESIDENT AND CFO | M · Exercise10b5-1 | $2.35 | +134,886 | 48,116 | — | $317K |